Share

Alternating Electric Fields (TTFields) Activate Cav1.2 Channels in Human Glioblastoma

PAPERmanual2019In vitro studyEffect: mixedEvidence: Low

Abstract

Alternating Electric Fields (TTFields) Activate Cav1.2 Channels in Human Glioblastoma Cells Neuhaus E, Zirjacks L, Ganser K, Klumpp L, Schüler U, Zips D, Eckert F, Huber SM. Alternating Electric Fields (TTFields) Activate Cav1.2 Channels in Human Glioblastoma Cells. Cancers (Basel). 2019 Jan 18;11(1). pii: E110. doi: 10.3390/cancers11010110. Abstract Tumor treating fields (TTFields) represent a novel FDA-approved treatment modality for patients with newly diagnosed or recurrent glioblastoma multiforme. This therapy applies intermediate frequency alternating electric fields with low intensity to the tumor volume by the use of non-invasive transducer electrode arrays. Mechanistically, TTFields have been proposed to impair formation of the mitotic spindle apparatus and cytokinesis. In order to identify further potential molecular targets, here the effects of TTFields on Ca2+- signaling, ion channel activity in the plasma membrane, cell cycle, cell death, and clonogenic survival were tested in two human glioblastoma cell lines in vitro by fura-2 Ca2+ imaging, patch-clamp cell-attached recordings, flow cytometry and pre-plated colony formation assay. In addition, the expression of voltage-gated Ca2+ (Cav) channels was determined by real-time RT-PCR and their significance for the cellular TTFields response defined by knock-down and pharmacological blockade. As a result, TTFields stimulated in a cell line-dependent manner a Cav1.2-mediated Ca2+entry, G₁ or S phase cell cycle arrest, breakdown of the inner mitochondrial membrane potential and DNA degradation, and/or decline of clonogenic survival suggesting a tumoricidal action of TTFields. Moreover, inhibition of Cav1.2 by benidipine aggravated in one glioblastoma line the TTFields effects suggesting that Cav1.2-triggered signaling contributes to cellular TTFields stress response. In conclusion, the present study identified Cav1.2 channels as TTFields target in the plasma membrane and provides the rationale to combine TTFields therapy with Ca2+ antagonists that are already in clinical use. mdpi.com

AI evidence extraction

At a glance
Study type
In vitro study
Effect direction
mixed
Population
Two human glioblastoma cell lines (in vitro)
Sample size
—
Exposure
tumor treating fields (TTFields) therapy
Evidence strength
Low
Confidence: 74% · Peer-reviewed: yes

Main findings

TTFields stimulated, in a cell line-dependent manner, Cav1.2-mediated Ca2+ entry and were associated with G1 or S phase cell cycle arrest, mitochondrial membrane potential breakdown, DNA degradation, and/or reduced clonogenic survival. Inhibition of Cav1.2 by benidipine aggravated TTFields effects in one glioblastoma line, suggesting Cav1.2-related signaling contributes to a cellular stress response to TTFields.

Outcomes measured

  • Ca2+ signaling
  • Ion channel activity (Cav1.2-mediated Ca2+ entry)
  • Cell cycle arrest (G1 or S phase)
  • Inner mitochondrial membrane potential breakdown
  • DNA degradation
  • Cell death
  • Clonogenic survival
  • Voltage-gated Ca2+ (Cav) channel expression
  • Effect modification by Cav1.2 inhibition (benidipine)
  • knock-down
  • pharmacological blockade

Limitations

  • In vitro study in two glioblastoma cell lines
  • generalizability to humans/clinical outcomes not addressed in the abstract
  • Exposure parameters (frequency
  • intensity
  • duration) not specified in the abstract
  • Cell line-dependent responses reported
View raw extracted JSON
{
  "study_type": "in_vitro",
  "exposure": {
    "band": null,
    "source": "tumor treating fields (TTFields) therapy",
    "frequency_mhz": null,
    "sar_wkg": null,
    "duration": null
  },
  "population": "Two human glioblastoma cell lines (in vitro)",
  "sample_size": null,
  "outcomes": [
    "Ca2+ signaling",
    "Ion channel activity (Cav1.2-mediated Ca2+ entry)",
    "Cell cycle arrest (G1 or S phase)",
    "Inner mitochondrial membrane potential breakdown",
    "DNA degradation",
    "Cell death",
    "Clonogenic survival",
    "Voltage-gated Ca2+ (Cav) channel expression",
    "Effect modification by Cav1.2 inhibition (benidipine), knock-down, pharmacological blockade"
  ],
  "main_findings": "TTFields stimulated, in a cell line-dependent manner, Cav1.2-mediated Ca2+ entry and were associated with G1 or S phase cell cycle arrest, mitochondrial membrane potential breakdown, DNA degradation, and/or reduced clonogenic survival. Inhibition of Cav1.2 by benidipine aggravated TTFields effects in one glioblastoma line, suggesting Cav1.2-related signaling contributes to a cellular stress response to TTFields.",
  "effect_direction": "mixed",
  "limitations": [
    "In vitro study in two glioblastoma cell lines; generalizability to humans/clinical outcomes not addressed in the abstract",
    "Exposure parameters (frequency, intensity, duration) not specified in the abstract",
    "Cell line-dependent responses reported"
  ],
  "evidence_strength": "low",
  "confidence": 0.74,
  "peer_reviewed_likely": "yes",
  "keywords": [
    "TTFields",
    "tumor treating fields",
    "alternating electric fields",
    "glioblastoma",
    "Cav1.2",
    "voltage-gated calcium channels",
    "Ca2+ imaging",
    "patch-clamp",
    "cell cycle arrest",
    "clonogenic survival",
    "benidipine"
  ],
  "suggested_hubs": [
    {
      "slug": "cancer-ttfields",
      "weight": 0.95,
      "reason": "Study investigates tumor treating fields (TTFields) mechanisms and cellular effects in glioblastoma cells."
    }
  ]
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract/metadata and may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.

NNEMF synthesis

Synthesis pending.

Original record: rfsafe.org paper 1906

Alternating Electric Fields (TTFields) Activate Cav1.2 Channels in Human Glioblastoma · Non-native EMF